Browsing by Author Hardy, Melinda

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2013A flow cytometry based assay for the enumeration of regulatory T cells in whole bloodHart, Derek; Hardy, Melinda; Prue, R; Rossetti, T; Vari, F; Concord Clinical School: ANZAC Research InstituteA flow cytometry based assay for the enumeration of regulatory T cells in whole blood, Journal of Immunological Methods, vol.390, 1-2, 2013,pp 121-126
2012Human CD1c (BDCA-1)+ myeloid dendritic cells secrete IL-10 and display an immuno-regulatory phenotype and function in response to Escherichia coliHart, Derek; Ding, Yitian; Hardy, Melinda; Jongbloed, Sarah; Ju, Xinsheng; Kassianos, Andrew; McDonald, Kylie; Radford, Kristen J; Vijayan, Dipti; Vulink, Annelie; Wadley, Robert; Wells, Christine; Concord Clinical School: ANZAC Research InstituteHuman CD1c (BDCA-1)+ myeloid dendritic cells secrete IL-10 and display an immuno-regulatory phenotype and function in response to Escherichia coli, European Journal of Immunology, vol.42, 6, 2012,pp 1512-1522
2015A phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A*0201 peptides for immunotherapy of metastatic hormone refractory prostate cancerHart, Derek; Coleman, Robert; D'Rozario, Rachael; et al, Various; Hardy, Melinda; Prue, R; Radford, Kristen; Rossetti, T; Tong, Hui; Tracey, Christopher; Vari, F; Waterhouse, Nigel; Concord Clinical School: ANZAC Research InstituteA phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A*0201 peptides for immunotherapy of metastatic hormone refractory prostate cancer, Journal of Immunotherapy, vol.38, 2, 2015,pp 71-76